- 1 analyst, 1 voteThe latest Buy, Hold or Sell from every analyst covering a stock.
- Price targetsTheir average target, the range, and the upside against today's price.
- Radar picks →The stocks our model scores highest in each index.
Russell 2000 analyst ratings
1,952 stocks · 1,852 covered · 15,462 votes ·
Ranking as of analyst data of 7 Nov 2026
| #Stock | Price · day | Buy / Hold / Sell | Avg target · range (USD) | Upside | Latest target report | Next earnings | Data status | Analysts | Report dates |
|---|---|---|---|---|---|---|---|---|---|
| 131.73+2.82% | Buy 27 · Hold 3 · Sell 0 · 90% Buy | 138.38100.00–180.00 | +5.0%+6.65 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:08 ET | 3229 firms | avg 10 Aug10 Dec 2025 – 30 Oct 2026 | |
| 52.65+14.58% | Buy 26 · Hold 2 · Sell 0 · 93% Buy | 146.0479.00–275.00 | +177.4%+93.39 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:06 ET | 3129 firms | avg 7 Aug26 Feb 2026 – 30 Oct 2026 | |
| 11.76+3.34% | Buy 24 · Hold 2 · Sell 0 · 92% Buy | 31.4816.00–40.00 | +167.7%+19.72 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:39 ET | 2927 firms | avg 13 Aug3 Mar 2026 – 2 Nov 2026 | |
| 28.35−1.84% | Buy 24 · Hold 3 · Sell 0 · 89% Buy | 34.3628.00–44.00 | +21.2%+6.01 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:48 ET | 2928 firms | avg 25 Jul4 Feb 2026 – 19 Oct 2026 | |
| 206.57−2.86% | Buy 23 · Hold 5 · Sell 0 · 82% Buy | 254.05175.00–310.00 | +23.0%+47.48 USD | 3 NovPartial coverage · checked 6 Nov | 27 JanEstimated | Partial coverage6 Nov 02:36 ET | 2927 firms | avg 2 Sep16 Mar 2026 – 3 Nov 2026 | |
| 16.71+13.21% | Buy 23 · Hold 2 · Sell 0 · 92% Buy | 29.4713.00–42.00 | +76.4%+12.76 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:36 ET | 2624 firms | avg 13 Aug19 Feb 2026 – 2 Nov 2026 | |
| 53.69−3.35% | Buy 22 · Hold 3 · Sell 0 · 88% Buy | 108.8066.00–146.00 | +102.6%+55.11 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:35 ET | 2625 firms | avg 29 Jul6 May 2026 – 19 Oct 2026 | |
| 33.27+9.59% | Buy 21 · Hold 1 · Sell 0 · 95% Buy | 70.4455.00–90.00 | +111.7%+37.17 USD | 19 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 02:40 ET | 2323 firms | avg 19 Aug5 Jun 2026 – 19 Oct 2026 | |
| 86.03+3.64% | Buy 21 · Hold 1 · Sell 0 · 95% Buy | 137.45113.00–200.00 | +59.8%+51.42 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:43 ET | 2423 firms | avg 13 Jun9 Mar 2026 – 27 Oct 2026 | |
| 3.37+4.50% | Buy 21 · Hold 2 · Sell 0 · 91% Buy | 20.2510.00–47.00 | +501.8%+16.89 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:16 ET | 2726 firms | avg 8 Jul8 Dec 2025 – 29 Oct 2026 | |
| 6.55+17.93% | Buy 20 · Hold 4 · Sell 0 · 83% Buy | 27.2310.50–51.50 | +316.0%+20.68 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:09 ET | 2525 firms | avg 4 Aug25 Feb 2026 – 29 Oct 2026 | |
| 100.98+35.33% | Buy 20 · Hold 2 · Sell 0 · 91% Buy | 107.7251.00–125.00 | +6.7%+6.74 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:05 ET | 2927 firms | avg 10 Aug26 Feb 2026 – 28 Oct 2026 | |
| 4.18+4.37% | Buy 20 · Hold 1 · Sell 0 · 95% Buy | 11.677.00–17.00 | +179.1%+7.49 USD | 22 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 06:59 ET | 2221 firms | avg 21 Jul25 Nov 2025 – 22 Oct 2026 | |
| 277.62+5.72% | Buy 20 · Hold 1 · Sell 1 · 91% Buy | 661.65362.00–1,201.00 | +138.3%+384.03 USD | 21 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 02:36 ET | 2524 firms | avg 4 Aug23 Feb 2026 – 21 Oct 2026 | |
| 10.29+16.01% | Buy 19 · Hold 1 · Sell 0 · 95% Buy | 27.3518.00–40.00 | +165.8%+17.06 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:00 ET | 2119 firms | avg 1 Sep5 May 2026 – 27 Oct 2026 | |
| 5.97+0.84% | Buy 19 · Hold 4 · Sell 0 · 83% Buy | 10.666.00–17.00 | +78.5%+4.69 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:58 ET | 2525 firms | avg 16 Jul4 Dec 2025 – 26 Oct 2026 | |
| 67.15+1.96% | Buy 18 · Hold 1 · Sell 0 · 95% Buy | 80.7649.00–92.00 | +20.3%+13.61 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:35 ET | 2121 firms | avg 31 Aug2 Mar 2026 – 3 Nov 2026 | |
| 27.97−1.31% | Buy 18 · Hold 3 · Sell 0 · 86% Buy | 33.4428.00–40.00 | +19.6%+5.47 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:37 ET | 2220 firms | avg 23 Sep5 May 2026 – 3 Nov 2026 | |
| 115.76−0.19% | Buy 18 · Hold 2 · Sell 0 · 90% Buy | 122.5790.00–145.00 | +5.9%+6.81 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:40 ET | 2121 firms | avg 26 Sep13 Jul 2026 – 3 Nov 2026 | |
| 18.80−0.21% | Buy 18 · Hold 3 · Sell 0 · 86% Buy | 21.4618.50–24.00 | +14.1%+2.66 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:56 ET | 2220 firms | avg 19 Aug2 Mar 2026 – 26 Oct 2026 | |
| 8.82+3.89% | Buy 18 · Hold 2 · Sell 0 · 90% Buy | 20.8814.00–27.00 | +136.7%+12.06 USD | 28 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:06 ET | 2121 firms | avg 23 Jul24 Feb 2026 – 28 Oct 2026 | |
| 24.42+2.01% | Buy 18 · Hold 2 · Sell 0 · 90% Buy | 31.4224.00–40.00 | +28.7%+7.00 USD | 17 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:52 ET | 2020 firms | avg 29 May13 Nov 2025 – 17 Sep 2026 | |
| 112.28+6.91% | Buy 18 · Hold 2 · Sell 0 · 90% Buy | 143.26120.00–166.00 | +27.6%+30.98 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:38 ET | 2524 firms | avg 23 Jun12 Dec 2025 – 4 Nov 2026 | |
| 103.86+7.53% | Buy 18 · Hold 2 · Sell 0 · 90% Buy | 117.1880.00–130.00 | +12.8%+13.32 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:07 ET | 2221 firms | avg 4 Aug13 Apr 2026 – 19 Oct 2026 | |
| 4.33+5.87% | Buy 18 · Hold 1 · Sell 0 · 95% Buy | 12.889.00–19.00 | +197.3%+8.55 USD | 17 SepPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 06:01 ET | 2119 firms | avg 29 May4 Dec 2025 – 17 Sep 2026 | |
| 12.85+1.54% | Buy 17 · Hold 1 · Sell 0 · 94% Buy | 19.1817.00–24.00 | +49.3%+6.33 USD | 5 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 07:00 ET | 1915 firms | avg 24 Jul12 May 2026 – 5 Oct 2026 | |
| 28.12−17.63% | Buy 17 · Hold 7 · Sell 0 · 71% Buy | 35.8624.00–50.00 | +27.5%+7.74 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:49 ET | 2624 firms | avg 10 Aug15 Jan 2026 – 28 Oct 2026 | |
| 18.71+4.50% | Buy 17 · Hold 2 · Sell 0 · 89% Buy | 34.7124.00–40.00 | +85.5%+16.00 USD | 27 OctPartial coverage · checked 6 Nov | 10 NovEstimated | Partial coverage6 Nov 05:50 ET | 2020 firms | avg 23 Jul4 Mar 2026 – 27 Oct 2026 | |
| 90.22−30.70% | Buy 17 · Hold 2 · Sell 0 · 89% Buy | 168.64147.00–194.00 | +86.9%+78.42 USD | 16 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:44 ET | 2020 firms | avg 24 Jul1 May 2026 – 16 Oct 2026 | |
| 27.91+9.84% | Buy 17 · Hold 2 · Sell 0 · 89% Buy | 97.0060.00–130.00 | +247.5%+69.09 USD | 26 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 04:46 ET | 2020 firms | avg 28 Jul30 Mar 2026 – 26 Oct 2026 | |
| 23.67+0.64% | Buy 17 · Hold 7 · Sell 0 · 71% Buy | 32.2726.00–39.00 | +36.3%+8.60 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:38 ET | 2725 firms | avg 21 Aug2 Jan 2026 – 2 Nov 2026 | |
| 132.04−2.38% | Buy 17 · Hold 0 · Sell 0 · 100% Buy | 170.44106.00–225.00 | +29.1%+38.40 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 08:15 ET | 1919 firms | avg 10 Aug19 Mar 2026 – 21 Oct 2026 | |
| 18.60+9.41% | Buy 17 · Hold 1 · Sell 0 · 94% Buy | 26.5018.00–32.00 | +42.5%+7.90 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:46 ET | 2018 firms | avg 7 Jul2 Mar 2026 – 26 Oct 2026 | |
| 48.22+0.54% | Buy 17 · Hold 3 · Sell 0 · 85% Buy | 70.8053.00–78.00 | +46.8%+22.58 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:51 ET | 2423 firms | avg 24 Aug11 Feb 2026 – 4 Nov 2026 | |
| 57.77+14.28% | Buy 17 · Hold 0 · Sell 0 · 100% Buy | 93.2460.00–120.00 | +61.4%+35.47 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:42 ET | 2019 firms | avg 17 Aug27 Jan 2026 – 3 Nov 2026 | |
| 71.89+2.96% | Buy 17 · Hold 14 · Sell 0 · 55% Buy | 85.1764.00–148.00 | +18.5%+13.28 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:52 ET | 3231 firms | avg 21 Jul2 Mar 2026 – 30 Oct 2026 | |
| 46.94+3.16% | Buy 17 · Hold 1 · Sell 0 · 94% Buy | 68.4048.00–84.00 | +45.7%+21.46 USD | 13 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 04:10 ET | 2018 firms | avg 28 Aug5 Mar 2026 – 13 Oct 2026 | |
| 14.33+11.87% | Buy 17 · Hold 1 · Sell 0 · 94% Buy | 27.9419.00–40.00 | +95.0%+13.61 USD | 14 AugPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 03:02 ET | 2016 firms | avg 15 Jun14 Nov 2025 – 14 Aug 2026 | |
| 39.17+3.95% | Buy 17 · Hold 2 · Sell 0 · 89% Buy | 73.0646.00–97.00 | +86.5%+33.89 USD | 8 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 02:43 ET | 2222 firms | avg 5 Aug10 Feb 2026 – 8 Oct 2026 | |
| 45.90+3.05% | Buy 17 · Hold 5 · Sell 1 · 74% Buy | 56.7838.00–83.00 | +23.7%+10.88 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:36 ET | 2422 firms | avg 31 Jul13 Nov 2025 – 4 Nov 2026 | |
| 49.43+10.36% | Buy 17 · Hold 0 · Sell 1 · 94% Buy | 72.9360.00–82.00 | +47.5%+23.50 USD | 19 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 02:50 ET | 1917 firms | avg 11 Aug11 May 2026 – 19 Oct 2026 | |
| 103.63+0.16% | Buy 17 · Hold 1 · Sell 1 · 89% Buy | 116.8389.00–142.00 | +12.7%+13.20 USD | 21 OctPartial coverage · checked 6 Nov | 1 DecConfirmed | Partial coverage6 Nov 04:06 ET | 2220 firms | avg 13 Jul17 Feb 2026 – 21 Oct 2026 | |
| 7.44−4.62% | Buy 16 · Hold 2 · Sell 0 · 89% Buy | 15.918.00–24.00 | +113.9%+8.47 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:00 ET | 2018 firms | avg 8 Aug2 Dec 2025 – 30 Oct 2026 | |
| 20.07+1.77% | Buy 16 · Hold 3 · Sell 0 · 84% Buy | 34.1920.00–42.00 | +70.3%+14.12 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:47 ET | 2221 firms | avg 24 Jul13 Mar 2026 – 4 Nov 2026 | |
| 7.27+6.91% | Buy 16 · Hold 2 · Sell 0 · 89% Buy | 28.6015.00–76.00 | +293.4%+21.33 USD | 14 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 06:08 ET | 2625 firms | avg 15 Jul24 Mar 2026 – 14 Oct 2026 | |
| 47.12−1.32% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 57.6051.00–68.00 | +22.2%+10.48 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:37 ET | 2017 firms | avg 13 Sep25 Jun 2026 – 30 Oct 2026 | |
| 6.60+2.57% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 25.9214.00–34.00 | +293.0%+19.32 USD | 20 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 05:55 ET | 1817 firms | avg 7 Aug3 Mar 2026 – 20 Oct 2026 | |
| 175.92+12.16% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 224.29200.00–267.00 | +27.5%+48.37 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:55 ET | 2121 firms | avg 19 May5 Dec 2025 – 28 Oct 2026 | |
| 24.44+3.04% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 69.5050.00–89.00 | +184.4%+45.06 USD | 22 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:08 ET | 1818 firms | avg 15 Sep10 Mar 2026 – 22 Oct 2026 | |
| 9.62+4.57% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 50.4534.00–60.00 | +424.5%+40.83 USD | 15 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:25 ET | 1817 firms | avg 14 Jul24 Mar 2026 – 15 Oct 2026 | |
- KYMR#1KYMERA THERAPEUTICS131.73+2.82%
Buy 27 · Hold 3 · Sell 0 · 90% Buy
Target 138.38 (100.00–180.00)+5.0%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 10 Dec 2025 – 30 Oct 2026 · avg 10 Aug 2026
- Analysts
- 32 analysts · 29 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- HUT#2HUT CORP52.65+14.58%
Buy 26 · Hold 2 · Sell 0 · 93% Buy
Target 146.04 (79.00–275.00)+177.4%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 26 Feb 2026 – 30 Oct 2026 · avg 7 Aug 2026
- Analysts
- 31 analysts · 29 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CORZ#3CORE SCIENTIFIC INC11.76+3.34%
Buy 24 · Hold 2 · Sell 0 · 92% Buy
Target 31.48 (16.00–40.00)+167.7%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 3 Mar 2026 – 2 Nov 2026 · avg 13 Aug 2026
- Analysts
- 29 analysts · 27 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- WAY#4WAYSTAR HOLDING28.35−1.84%
Buy 24 · Hold 3 · Sell 0 · 89% Buy
Target 34.36 (28.00–44.00)+21.2%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 4 Feb 2026 – 19 Oct 2026 · avg 25 Jul 2026
- Analysts
- 29 analysts · 28 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- EAT#5BRINKER INTERNATIONAL INC206.57−2.86%
Buy 23 · Hold 5 · Sell 0 · 82% Buy
Target 254.05 (175.00–310.00)+23.0%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 16 Mar 2026 – 3 Nov 2026 · avg 2 Sep 2026
- Analysts
- 29 analysts · 27 firms
- Next earnings
- 27 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- RIOT#6RIOT PLATFORMS16.71+13.21%
Buy 23 · Hold 2 · Sell 0 · 92% Buy
Target 29.47 (13.00–42.00)+76.4%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 19 Feb 2026 – 2 Nov 2026 · avg 13 Aug 2026
- Analysts
- 26 analysts · 24 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CYTK#7CYTOKINETICS53.69−3.35%
Buy 22 · Hold 3 · Sell 0 · 88% Buy
Target 108.80 (66.00–146.00)+102.6%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 6 May 2026 – 19 Oct 2026 · avg 29 Jul 2026
- Analysts
- 26 analysts · 25 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- DFTX#8DEFINIUM THERAPEUTICS INC33.27+9.59%
Buy 21 · Hold 1 · Sell 0 · 95% Buy
Target 70.44 (55.00–90.00)+111.7%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 5 Jun 2026 – 19 Oct 2026 · avg 19 Aug 2026
- Analysts
- 23 analysts · 23 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- DNTH#9DIANTHUS THERAPEUTICS INC86.03+3.64%
Buy 21 · Hold 1 · Sell 0 · 95% Buy
Target 137.45 (113.00–200.00)+59.8%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 9 Mar 2026 – 27 Oct 2026 · avg 13 Jun 2026
- Analysts
- 24 analysts · 23 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- WVE#10WAVE LIFE SCIENCES INC3.37+4.50%
Buy 21 · Hold 2 · Sell 0 · 91% Buy
Target 20.25 (10.00–47.00)+501.8%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 8 Dec 2025 – 29 Oct 2026 · avg 8 Jul 2026
- Analysts
- 27 analysts · 26 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CIFR#11CIPHER DIGITAL INC6.55+17.93%
Buy 20 · Hold 4 · Sell 0 · 83% Buy
Target 27.23 (10.50–51.50)+316.0%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 25 Feb 2026 – 29 Oct 2026 · avg 4 Aug 2026
- Analysts
- 25 analysts · 25 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- FROG#12JFROG100.98+35.33%
Buy 20 · Hold 2 · Sell 0 · 91% Buy
Target 107.72 (51.00–125.00)+6.7%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 26 Feb 2026 – 28 Oct 2026 · avg 10 Aug 2026
- Analysts
- 29 analysts · 27 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IRD#13OPUS GENETICS INC4.18+4.37%
Buy 20 · Hold 1 · Sell 0 · 95% Buy
Target 11.67 (7.00–17.00)+179.1%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 25 Nov 2025 – 22 Oct 2026 · avg 21 Jul 2026
- Analysts
- 22 analysts · 21 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- PRAX#14PRAXIS PRECISION MEDICINES277.62+5.72%
Buy 20 · Hold 1 · Sell 1 · 91% Buy
Target 661.65 (362.00–1,201.00)+138.3%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 23 Feb 2026 – 21 Oct 2026 · avg 4 Aug 2026
- Analysts
- 25 analysts · 24 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- CLYM#15CLIMB BIO INC10.29+16.01%
Buy 19 · Hold 1 · Sell 0 · 95% Buy
Target 27.35 (18.00–40.00)+165.8%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 5 May 2026 – 27 Oct 2026 · avg 1 Sep 2026
- Analysts
- 21 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- GENI#16GENIUS SPORTS LTD5.97+0.84%
Buy 19 · Hold 4 · Sell 0 · 83% Buy
Target 10.66 (6.00–17.00)+78.5%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 4 Dec 2025 – 26 Oct 2026 · avg 16 Jul 2026
- Analysts
- 25 analysts · 25 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BTSG#17BRIGHTSPRING HEALTH SERVICES INC67.15+1.96%
Buy 18 · Hold 1 · Sell 0 · 95% Buy
Target 80.76 (49.00–92.00)+20.3%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 2 Mar 2026 – 3 Nov 2026 · avg 31 Aug 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- EPRT#18ESSENTIAL PROPERTIES REALTY TRUST27.97−1.31%
Buy 18 · Hold 3 · Sell 0 · 86% Buy
Target 33.44 (28.00–40.00)+19.6%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 5 May 2026 – 3 Nov 2026 · avg 23 Sep 2026
- Analysts
- 22 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- HNGE#19HINGE HEALTH CLASS A115.76−0.19%
Buy 18 · Hold 2 · Sell 0 · 90% Buy
Target 122.57 (90.00–145.00)+5.9%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 13 Jul 2026 – 3 Nov 2026 · avg 26 Sep 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- NTST#20NETSTREIT18.80−0.21%
Buy 18 · Hold 3 · Sell 0 · 86% Buy
Target 21.46 (18.50–24.00)+14.1%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 2 Mar 2026 – 26 Oct 2026 · avg 19 Aug 2026
- Analysts
- 22 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ORIC#21ORIC PHARMACEUTICALS8.82+3.89%
Buy 18 · Hold 2 · Sell 0 · 90% Buy
Target 20.88 (14.00–27.00)+136.7%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 24 Feb 2026 – 28 Oct 2026 · avg 23 Jul 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- PRVA#22PRIVIA HEALTH GROUP INC24.42+2.01%
Buy 18 · Hold 2 · Sell 0 · 90% Buy
Target 31.42 (24.00–40.00)+28.7%
Details
- Latest target report
- 17 Sep 2026
- Report dates
- 13 Nov 2025 – 17 Sep 2026 · avg 29 May 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RYTM#23RHYTHM PHARMACEUTICALS112.28+6.91%
Buy 18 · Hold 2 · Sell 0 · 90% Buy
Target 143.26 (120.00–166.00)+27.6%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 12 Dec 2025 – 4 Nov 2026 · avg 23 Jun 2026
- Analysts
- 25 analysts · 24 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SYRE#24SPYRE THERAPEUTICS INC103.86+7.53%
Buy 18 · Hold 2 · Sell 0 · 90% Buy
Target 117.18 (80.00–130.00)+12.8%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 13 Apr 2026 – 19 Oct 2026 · avg 4 Aug 2026
- Analysts
- 22 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TSHA#25TAYSHA GENE THERAPIES4.33+5.87%
Buy 18 · Hold 1 · Sell 0 · 95% Buy
Target 12.88 (9.00–19.00)+197.3%
Details
- Latest target report
- 17 Sep 2026
- Report dates
- 4 Dec 2025 – 17 Sep 2026 · avg 29 May 2026
- Analysts
- 21 analysts · 19 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- DSP#26VIANT TECHNOLOGY INC CLASS A12.85+1.54%
Buy 17 · Hold 1 · Sell 0 · 94% Buy
Target 19.18 (17.00–24.00)+49.3%
Details
- Latest target report
- 5 Oct 2026
- Report dates
- 12 May 2026 – 5 Oct 2026 · avg 24 Jul 2026
- Analysts
- 19 analysts · 15 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- FIVN#27FIVE928.12−17.63%
Buy 17 · Hold 7 · Sell 0 · 71% Buy
Target 35.86 (24.00–50.00)+27.5%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 15 Jan 2026 – 28 Oct 2026 · avg 10 Aug 2026
- Analysts
- 26 analysts · 24 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IMNM#28IMMUNOME18.71+4.50%
Buy 17 · Hold 2 · Sell 0 · 89% Buy
Target 34.71 (24.00–40.00)+85.5%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 4 Mar 2026 – 27 Oct 2026 · avg 23 Jul 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- 10 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- IRTC#29IRHYTHM HOLDINGS INC90.22−30.70%
Buy 17 · Hold 2 · Sell 0 · 89% Buy
Target 168.64 (147.00–194.00)+86.9%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 1 May 2026 – 16 Oct 2026 · avg 24 Jul 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LGN#30LEGENCE CLASS A27.91+9.84%
Buy 17 · Hold 2 · Sell 0 · 89% Buy
Target 97.00 (60.00–130.00)+247.5%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 30 Mar 2026 – 26 Oct 2026 · avg 28 Jul 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- MGY#31MAGNOLIA OIL GAS CORP CLASS A23.67+0.64%
Buy 17 · Hold 7 · Sell 0 · 71% Buy
Target 32.27 (26.00–39.00)+36.3%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 2 Jan 2026 – 2 Nov 2026 · avg 21 Aug 2026
- Analysts
- 27 analysts · 25 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PTGX#32PROTAGONIST THERAPEUTICS132.04−2.38%
Buy 17 · Hold 0 · Sell 0 · 100% Buy
Target 170.44 (106.00–225.00)+29.1%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 19 Mar 2026 – 21 Oct 2026 · avg 10 Aug 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RLAY#33RELAY THERAPEUTICS18.60+9.41%
Buy 17 · Hold 1 · Sell 0 · 94% Buy
Target 26.50 (18.00–32.00)+42.5%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 2 Mar 2026 – 26 Oct 2026 · avg 7 Jul 2026
- Analysts
- 20 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RRR#34RED ROCK RESORTS ORS CLASS A48.22+0.54%
Buy 17 · Hold 3 · Sell 0 · 85% Buy
Target 70.80 (53.00–78.00)+46.8%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 11 Feb 2026 – 4 Nov 2026 · avg 24 Aug 2026
- Analysts
- 24 analysts · 23 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SEI#35SOLARIS ENERGY INFRASTRUCTURE INC57.77+14.28%
Buy 17 · Hold 0 · Sell 0 · 100% Buy
Target 93.24 (60.00–120.00)+61.4%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 27 Jan 2026 – 3 Nov 2026 · avg 17 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SHAK#36SHAKE SHACK INC CLASS A71.89+2.96%
Buy 17 · Hold 14 · Sell 0 · 55% Buy
Target 85.17 (64.00–148.00)+18.5%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 2 Mar 2026 – 30 Oct 2026 · avg 21 Jul 2026
- Analysts
- 32 analysts · 31 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SRRK#37SCHOLAR ROCK HOLDING46.94+3.16%
Buy 17 · Hold 1 · Sell 0 · 94% Buy
Target 68.40 (48.00–84.00)+45.7%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 5 Mar 2026 – 13 Oct 2026 · avg 28 Aug 2026
- Analysts
- 20 analysts · 18 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- TRVI#38TREVI THERAPEUTICS14.33+11.87%
Buy 17 · Hold 1 · Sell 0 · 94% Buy
Target 27.94 (19.00–40.00)+95.0%
Details
- Latest target report
- 14 Aug 2026
- Report dates
- 14 Nov 2025 – 14 Aug 2026 · avg 15 Jun 2026
- Analysts
- 20 analysts · 16 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- XENE#39XENON PHARMACEUTICALS39.17+3.95%
Buy 17 · Hold 2 · Sell 0 · 89% Buy
Target 73.06 (46.00–97.00)+86.5%
Details
- Latest target report
- 8 Oct 2026
- Report dates
- 10 Feb 2026 – 8 Oct 2026 · avg 5 Aug 2026
- Analysts
- 22 analysts · 22 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- ALKS#40ALKERMES45.90+3.05%
Buy 17 · Hold 5 · Sell 1 · 74% Buy
Target 56.78 (38.00–83.00)+23.7%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 13 Nov 2025 – 4 Nov 2026 · avg 31 Jul 2026
- Analysts
- 24 analysts · 22 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ELVN#41ENLIVEN THERAPEUTICS49.43+10.36%
Buy 17 · Hold 0 · Sell 1 · 94% Buy
Target 72.93 (60.00–82.00)+47.5%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 11 May 2026 – 19 Oct 2026 · avg 11 Aug 2026
- Analysts
- 19 analysts · 17 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- HQY#42HEALTHEQUITY103.63+0.16%
Buy 17 · Hold 1 · Sell 1 · 89% Buy
Target 116.83 (89.00–142.00)+12.7%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 17 Feb 2026 – 21 Oct 2026 · avg 13 Jul 2026
- Analysts
- 22 analysts · 20 firms
- Next earnings
- 1 Dec · Confirmed
- Research
- Partial coverage · checked 6 Nov
- ATEC#43ALPHATEC HOLDNGS7.44−4.62%
Buy 16 · Hold 2 · Sell 0 · 89% Buy
Target 15.91 (8.00–24.00)+113.9%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 2 Dec 2025 – 30 Oct 2026 · avg 8 Aug 2026
- Analysts
- 20 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- DNLI#44DENALI THERAPEUTICS20.07+1.77%
Buy 16 · Hold 3 · Sell 0 · 84% Buy
Target 34.19 (20.00–42.00)+70.3%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 13 Mar 2026 – 4 Nov 2026 · avg 24 Jul 2026
- Analysts
- 22 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- KURA#45KURA ONCOLOGY7.27+6.91%
Buy 16 · Hold 2 · Sell 0 · 89% Buy
Target 28.60 (15.00–76.00)+293.4%
Details
- Latest target report
- 14 Oct 2026
- Report dates
- 24 Mar 2026 – 14 Oct 2026 · avg 15 Jul 2026
- Analysts
- 26 analysts · 25 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- LTH#46LIFE TIME GROUP HOLDINGS47.12−1.32%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 57.60 (51.00–68.00)+22.2%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 25 Jun 2026 – 30 Oct 2026 · avg 13 Sep 2026
- Analysts
- 20 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- OCUL#47OCULAR THERAPEUTIX6.60+2.57%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 25.92 (14.00–34.00)+293.0%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 3 Mar 2026 – 20 Oct 2026 · avg 7 Aug 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- PVLA#48PALVELLA THERAPEUTICS INC175.92+12.16%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 224.29 (200.00–267.00)+27.5%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 5 Dec 2025 – 28 Oct 2026 · avg 19 May 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RAPP#49RAPPORT THERAPEUTICS24.44+3.04%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 69.50 (50.00–89.00)+184.4%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 10 Mar 2026 – 22 Oct 2026 · avg 15 Sep 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- STRO#50SUTRO BIOPHARMA INC9.62+4.57%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 50.45 (34.00–60.00)+424.5%
Details
- Latest target report
- 15 Oct 2026
- Report dates
- 24 Mar 2026 – 15 Oct 2026 · avg 14 Jul 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
Showing 1–50 of 1,952Load more
About the Russell 2000 analyst ratings
US small-cap stocks in the Russell 2000. Smaller companies usually have fewer analysts.. For each stock Analyst Radar counts the latest Buy, Hold or Sell rating of every analyst who covers it within the chosen window (one vote per analyst) and averages their price targets in US dollars. Upside is the average target against the current price; the range is the lowest and highest target. The stocks our model scores highest are collected in Radar picks. Research is refreshed daily and prices stream live during the US session.
A summary of analyst opinion, not investment advice.